Quarterly report pursuant to Section 13 or 15(d)

Securities Financing Agreements, Collateral and Restricted Cash - Securities Financing Agreements (Details)

v3.22.2.2
Securities Financing Agreements, Collateral and Restricted Cash - Securities Financing Agreements (Details) - USD ($)
$ in Millions
Sep. 30, 2022
Dec. 31, 2021
Securities borrowed or purchased under agreements to resell    
Gross Assets/Liabilities $ 550,757 $ 527,054
Amounts Offset (275,510) (276,334)
Net Balance Sheet Amount 275,247 250,720
Financial Instruments (251,549) (229,525)
Net Assets/Liabilities 23,698 21,195
Securities loaned or sold under agreements to repurchase    
Gross Liabilities 491,137 468,663
Amounts Offset (275,510) (276,334)
Net Balance Sheet Amount 215,627 192,329
Financial Instruments (201,129) (181,860)
Net Liabilities 14,498 10,469
Other    
Gross Liabilities 6,564 11,391
Amounts Offset 0 0
Net Balance Sheet Amount 6,564 11,391
Financial Instruments (6,564) (11,391)
Net Liabilities 0 0
Total Securities Financing Agreements Liability    
Gross Liabilities 497,701 480,054
Amounts Offset (275,510) (276,334)
Net Balance Sheet Amount 222,191 203,720
Financial Instruments (207,693) (193,251)
Net Liabilities 14,498 10,469
Loans and leases repurchase activity $ 9,200 $ 20,100